TrialSignal transduction and targeted therapy2024

Systemic longitudinal immune profiling identifies proliferating Treg cells as predictors of immunotherapy benefit: biomarker analysis from the phase 3 CONTINUUM and DIPPER trials.

Sai-Wei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.